financetom
Business
financetom
/
Business
/
Apollo Global Management's CareerBuilder + Monster Begins Chapter 11 to Sell Business Units
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apollo Global Management's CareerBuilder + Monster Begins Chapter 11 to Sell Business Units
Jun 24, 2025 8:07 AM

10:45 AM EDT, 06/24/2025 (MT Newswires) -- CareerBuilder + Monster, a portfolio company backed by Apollo Global Management ( APO ) and Randstad, said Tuesday it initiated a voluntary Chapter 11 process in the US Bankruptcy Court for the District of Delaware to facilitate the sale of its businesses, preserve jobs, and maximize value.

The company said it entered into asset purchase agreements to sell its job board business to JobGet, Monster Media Properties to Valnet, and Monster Government Services to Valsoft.

CareerBuilder + Monster is also finalizing an agreement with Blue Torch Capital for up to $20 million in debtor-in-possession financing to support operations during the court-supervised sale process, it said.

Shares of Apollo Global were up nearly 3% in recent trading.

Price: 137.81, Change: +3.78, Percent Change: +2.82

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nano One Materials Advances Candiac LFP Production Capacity Expansion Project
Nano One Materials Advances Candiac LFP Production Capacity Expansion Project
Mar 17, 2026
07:13 AM EDT, 03/17/2026 (MT Newswires) -- Nano One Materials ( NNOMF ) on Tuesday provided a progress update on its lithium iron phosphate (LFP) production capacity expansion project at its Candiac facility, which it said will result in an increased capacity of 800 tonnes per annum (tpa). The company said purchase orders for major equipment have been issued and...
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints
Mar 17, 2026
Rhythm Pharmaceuticals Inc. ( RYTM ) shares are down during Tuesday’s premarket session following the Monday announcement of topline results from its EMANATE trial. EMANATE was a Phase 3 trial designed to evaluate the efficacy and safety of setmelanotide in patients with rare, genetically driven obesities of the MC4R pathway. EMANATE Trial Misses Primary Endpoints In the EMANATE trial, Rhythm...
Form 8.3
Form 8.3
Mar 17, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Victory Capital submits new bid for rival Janus Henderson
Victory Capital submits new bid for rival Janus Henderson
Mar 17, 2026
March 17 (Reuters) - Victory Capital ( VCTR ) on Tuesday submitted a new bid to acquire rival asset manager Janus Henderson ( JHG ). Under the revised proposal, San Antonio-based Victory is offering $40 in cash and 0.25 of its shares for each Janus share. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved